A 34-year-old man with refractory acute myelogenous leukemia underwent allogeneic peripheral blood stem cell transplantation (PBSCT) from his HLA-matched sibling. Engraftment was prompt and no acute GVHD developed. However, high fever persisted even after engraftment, and the patient developed headache, diplopia, vertigo and nuchal rigidity on day 20 posttransplant. Cerebrospinal fluid (CSF) showed pleocytosis with no detectable microorganisms. Despite therapy with broad-spectrum antibiotics, antifungal agents and antituberculous drugs, he developed rapid mental deterioration with seizures and died on day 40. Just prior to his death, trichomonads were isolated from both CSF and urine. Scanning electron microscopic examination identified the trichomonad as Trichomonas foetus. At autopsy, trichomonads were detected histopathologically in an area involving meningoencephalitis. To our knowledge, this is the first case of T. foetus meningoencephalitis in a recipient of allogeneic PBSCT and, more importantly, the first human case of T. foetus infection. Keywords: trichomonad; meningitis; infection; allogeneic transplantation; peripheral blood stem cell Trichomoniasis is a commonly reported sexually transmitted disease occurring both in animals and humans. Trichomonads are known to have strict host specificity, and Trichomonas foetus is associated in nature only with bovine diseases such as vaginitis. However, T. foetus infection in humans has never been reported.
Trichomoniasis is a commonly reported sexually transmitted disease occurring both in animals and humans. Trichomonads are known to have strict host specificity, and Trichomonas foetus is associated in nature only with bovine diseases such as vaginitis. However, T. foetus infection in humans has never been reported. 1, 2 Allogeneic peripheral blood stem cell transplantation (alloPBSCT) is increasingly employed in treating hematologic malignancies. Reported experience consistently shows rapid recovery of both granulocytes and platelets after alloPBSCT. However, data on immune recovery and infecCorrespondence: Dr S Okamoto, Keio BMT Program, Division of Hematology, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo 160, Japan Received 29 May 1997; accepted 21 August 1997 tious complications are relatively limited. [3] [4] [5] We describe the first case of T. foetus meningoencephalitis occurring in a severely immunosuppressed patient following alloPBSCT. To the best of our knowledge, this occurrence is also the first case of T. foetus infection in humans.
Case report
A 34-year-old man was diagnosed with AML in March 1995. Complete remission was achieved in May, but the leukemia subsequently became resistant to chemotherapy. The patient was referred to Keio University Hospital for marrow transplantation in February 1996. On admission he was neutropenic and subsequently developed necrotizing gingivitis and perianal abscess. These infections were treated successfully with broad-spectrum antibiotics, and he became afebrile. He then received BU (16 mg/kg) and CY (120 mg/kg) as conditioning. Non-T cell-depleted PBSC with 5.1 × 10 6 CD34-positive cells/kg of patient body weight were infused 2 days after completion of CY. PBSC had been collected from his HLA-matched brother using G-CSF. Cyclosporine as GVHD prophylaxis and G-CSF were given after transplantation. Engraftment was prompt, and the ANC reached 500/l on day 8. No acute GVHD occurred. BM examination on day 13 showed normo cellular marrow with trilineage hematopoiesis and no leukemic cells.
The patient became febrile during conditioning and was placed on antibiotics and amphotericin B. Temperature and C-reactive protein elevation slowly decreased, but he remained febrile even after recovery of neutrophils. On day 20 he developed vertigo, double vision and nuchal rigidity. Lumbar puncture yielded cloudy cerebrospinal fluid (CSF) with glucose, 35 mg/dl (serum glucose, 110 mg/dl); protein, 381 mg/dl; and a cell count of 1700/l (65% polymorphonuclear leukocytes and 35% monocytes and lymphocytes). Gram staining and culture of CSF showed no microorganisms. Despite therapy with systemic broad-spectrum antibiotics, isoniazid and refampicin and intrathecal gentamicin, he became unconscious with irregular respiration and seizures on day 23. Computed tomography of the brain revealed hydrocephalus. Percutaneous ventricular drainage was carried out, which temporarily improved his level of consciousness, but he soon again deteriorated neurologically. A painful left scrotal mass became evident at that time, and was diagnosed as epididymitis. The results of urinalysis and urine culture were unremarkable. Massive melena attributed to cytomegalovirus (CMV) enteritis occurred on day 26. Afterwards, his condition continued to deteriorate. Repeated CSF cultures and Gram staining were negative, and blood cultures also proved sterile. Finally, numerous trichomonads were detected in CSF and urine on day 39 (Figure 1a) . Administration of metronidazole by nasogastric tube was started the same day, but no improvement was observed and the patient died on day 40.
Trichomonads isolated from CSF were quantified as about 6.5 × 10 6 /ml. A specimen was fixed with glutaraldehyde and osmium tetroxide for electron microscopic examination. The body of the trichomonad was spindleshaped, 15.7 long and 7.8 wide, possessing three anterior flagella equal in length (13.6 ) and one posterior flagellum about as long as the anterior flagella trailing (Figure 1b) . None of the trichomonads possessed the five anterior flagella, ordinarily present in Pentatrichomonas hominis, a human intestinal trichomonad. Based on these morphologic findings the trichomonad was identified as T. foetus. 6 Autopsy revealed severe meningoencephalitis and ventriculitis. Histopathologic examination of the meninges showed trichomonads, with evidence of damage by inflammatory response (Figure 1c) . Left epididymitis and prostatitis related to trichomonads were also found. Disseminated CMV infection was evident in the gastrointestinal tract, lungs and adrenal glands. Neither CMV inclusion bodies nor CMV antigens were detected in the brain or genitourinary tract. Attempts at immunostaining for CMV included monoclonal antibodies to both early and late antigens. Immunostaining in the brain for T. foetus was attempted using polyclonal antibodies against T. foetus membrane glycoproteins but failed, possibly because of high background staining reflecting severe inflammation and subsequent destruction of trichomonads.
Discussion
This is the first report of human T. foetus infection, which presented as meningoencephalitis after alloPBSCT. Recipients of such transplants remain immunoincompetent and are susceptible to a variety of infections. However, neither meningitis nor meningoencephalitis is frequently encountered. Reported pathogens in post-transplant meningitis include Stomatococcus mucilaginosus, Blastoschizomyces captatus and Acantamoeba. [7] [8] [9] Virtually all cases of meningitis caused by these organisms occur within 3 months following transplantation. Streptococcus pneumoniae meningitis and Listeria monocytogenes meningitis have been reported later in the course of transplantation, and primarily in patients with chronic GVHD. 10, 11 To the best of our knowledge, no cases of T. foetus meningoencephalitis have been reported after stem cell transplantation or in any other circumstances involving human hosts. T. foetus is a protozoan parasite which ordinarily causes only naturally occurring bovine diseases, although various laboratory animals can be infected experimentally. Trichomonads live in the digestive and genital tracts of the host. In the bull the most common site of infection with T. foetus is the prepuce, although the testes, epididymis and the seminal vesicles may be involved.
1 Spontaneous recov-ery is rare, and bulls remain infected unless treated. A possibility exists that our patient may have been infected with the trichomonad prior to alloPBSCT. Although one urinalysis before transplantation showed trichomonads, thought at that time to be T. vaginalis, further examination was not performed. T. foetus may have been present in the region of the prepuce, subsequently infecting the central nervous system, prostate and epididymis. Although the portal of entry may have been the genitourinary tract, we lack a good explanation of how T. foetus infected this patient. Coitus with women or animals infected with T. foetus represents a possible explanation, but no information could be obtained regarding the patient's sexual partners or habits. Adherence to genital tract epithelial cells appears to be an important initial step in T. foetus infection. 12 Cysteine proteases have been also demonstrated to be important in adhesion of trichomonads. Mutation in trichomonads may have given rise to surface glycoproteins or enzymes making cross-species infection possible. We are currently investigating these possibilities.
In this case, we speculated that trichomonad infection was limited and the patient was asymptomatic prior to alloPBSCT, probably reflecting acquired immunity against T. foetus. Disruption of his immune system by conditioning eliminated its capacity to limit the infection. Although the patient received intravenous immunoglobulin during the peritransplant period, intravenous immunoglobulin products from normal human donors are unlikely to contain antibodies against T. foetus. Whether recipients of alloPBSCT have more delayed or defective reconstitution of their immune systems after transplant than patients transplanted with bone marrow is not known. However, several reports to date suggest that alloPBSCT may accelerate immunologic reconstitution, 13 and we do not believe that alloPBSCT made this patient more susceptible to the organism than alloBMT would have. In conclusion, this case suggests that we should be aware of the possibility of unusual infections in severely immunocompromised hosts, including those caused by microorganisms isolated exclusively from animal.
